Plasma heart-type fatty acid binding protein is superior to troponin and myoglobin for rapid risk stratification in acute pulmonary embolism

Clinica Chimica Acta

Volumn 371, Issue 1-2, 2006, Pages 117-123

  Kaczyñska, Anna ^a   Pelsers, Maurice M A L ^b   Bochowicz, Anna ^a   Kostrubiec, Maciej ^a   Glatz, Jan F C ^b   Pruszczyk, Piotr ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Acute pulmonary embolism; Heart type fatty acid binding protein; Risk stratification

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; FATTY ACID BINDING PROTEIN; MYOGLOBIN; TROPONIN T;

AGED; ARTICLE; BLOOD CLOT LYSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; COURSE EVALUATION; DIAGNOSTIC ACCURACY; DISEASE COURSE; DISEASE MARKER; FEMALE; HAZARD ASSESSMENT; HEART DEATH; HEART MUSCLE INJURY; HEART RIGHT VENTRICLE OVERLOAD; HOSPITAL ADMISSION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESUSCITATION; RISK ASSESSMENT; SAMPLE SIZE; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD PRESSURE; CARDIOPULMONARY RESUSCITATION; ECHOCARDIOGRAPHY; FATTY ACID-BINDING PROTEINS; HUMANS; MIDDLE AGED; MYOGLOBIN; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROGNOSIS; PULMONARY EMBOLISM; RISK ASSESSMENT; THROMBOLYTIC THERAPY; TROPONIN; VASOCONSTRICTOR AGENTS;

EID: 33746691850     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.02.032     Document Type: Article

References (30)

1. Goldhaber S.Z., Visani L., and De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry. Lancet 353 (1999) 1386-1389
2. Konstantinides S., Geibel A., Olscheski M., et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 106 (2002) 1263-1268
3. Kucher N., and Goldhaber S.Z. Cardiac biomarkers for risk stratification of patients with acute pulmonary embolism. Circulation 108 (2003) 2191-2194
4. Pruszczyk P., Bochowicz A., Kostrubiec M., et al. Myoglobin stratifies short-term risk in acute major pulmonary embolism. Clin Chim Acta 338 (2003) 53-56
5. Pruszczyk P., Bochowicz A., Torbicki A., et al. Cardiac troponin T monitoring identifies high-risk group of normotensive patients with acute pulmonary embolism. Chest 123 (2003) 1947-1952
6. Kucher N., Printzen G., and Goldhaber S.Z. Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation 107 (2003) 2545-2547
7. Binder L., Pieske B., Olschewski M., et al. N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation 6 (2005) 1573-1579
8. Kostrubiec M., Pruszczyk P., Bochowicz A., et al. Biomarker-based risk assessment model in acute pulmonary embolism. Eur Heart J 26 (2005) 2166-2172
9. Pelsers M.M., Hermens W.T., and Glatz J.F. Fatty acid-binding proteins as plasma markers of tissue injury. Clin Chim Acta 352 (2005) 15-35
10. Glatz J.F., and van der Vusse G.J. Cellular fatty acid-binding proteins: their function and physiological significance. Prog Lipid Res 35 (1996) 243-282
11. Storch J., and Thumser A.E. The fatty acid transport function of fatty acid-binding proteins. Biochim Biophys Acta 1486 (2000) 28-44
12. Glatz J.F., van Bilsen M., Paulussen R.J., Veerkamp J., van der Vusse G.J., and Reneman R.S. Release of fatty acid-binding protein from isolated rat heart subjected to ischemia and reperfusion or to the calcium paradox. Biochim Biophys Acta 961 (1988) 148-152
13. de Groot M.J., Wodzig K.W., Simoons M.L., Glatz J.F., and Hermens W.T. Measurement of myocardial size from plasma fatty acid-binding protein or myoglobin, using individually estimated clearance rates. Cardiovasc Res 45 (2000) 853-859
14. Nayashida N., Chihara S., Tayama E., et al. Influence of renal function on serum and urinary heart fatty acid-binding protein levels. J Cardiovasc Surg 42 (2001) 735-740
15. Glatz J.F., Kleine A.H., van Nieuwenhoven F.A., et al. Fatty acid-binding protein as a plasma marker for the estimation of myocardial infarct size in humans. Br Heart J 71 (1994) 135-140
16. Haastup B., Gill S., Kristensen S.R., et al. Biochemical markers of ischaemia for the early identification of acute myocardial infarction without ST segment elevation. Cardiology 94 (2000) 254-261
17. Nakata T., Hashimoto A., Hase M., Tsuchihashi K., and Shimamoto K. Human heart-type fatty acid-binding protein as an early diagnostic and prognostic marker in acute coronary syndrome. Cardiology 99 (2003) 96-104
18. Pruszczyk P., Torbicki A., Pacho R., et al. Noninvasive diagnosis of suspected severe pulmonary embolism: transesophageal echocardiography vs. spiral CT. Chest 112 3 (1997) 722-728
19. Myocardial infarction redefined-a consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarct. Eur Heart J 21 (2000) 1502-1513
20. Wodzig K.W.H., Pelsers M.M.A.L., Van der Vusse G.J., Roos W., and Glatz J.F.C. One-step enzyme-linked immunosorbent assay (ELISA) for plasma fatty acid-binding protein. Ann Clin Biochem 34 (1997) 263-268
21. Pelsers M.M.A.L., Chapelle J.P., Knapen M., et al. Influence of age, sex and day-to-day and within-day biological variation on plasma concentrations of fatty acid-binding protein and myoglobin in healthy subjects. Clin Chem 45 (1999) 441-443
22. Cannon C.P., and Goldhaber S.Z. Cardiovascular risk stratification of pulmonary embolism. Am J Cardiol 78 (1996) 1149-1151
23. Seino Y., Tomita Y., Takano T., and Ohbayashi K. Office cardiologists cooperative study on whole blood rapid panel tests in patients with suspicious acute myocardial infarction: comparison between heart-type fatty acid-binding protein and troponin T tests. Circ J 68 (2004) 144-148
24. Tambara K., Fujita M., Miyamoto S., et al. Pericardial fluid level of heart-type cytoplasmatic fatty acid-binding protein is an indicator of severe myocardial ischemia. Int J Cardiol 93 (2004) 281-284
25. Arimoto T., Takeishi Y., and Shiga R. Prognostic value of elevated circulating heart-type fatty acid binding protein in patients with congestive heart failure. J Card Fail 11 (2005) 56-60
26. Niizeki T., Takeishi Y., Arimoto T., et al. Combination of heart-type fatty acid binding protein and brain natriuretic peptide can reliably risk stratify patients hospitalized for chronic heart failure. Circ J 69 (2005) 922-927
27. Niizeki T., Takeishi Y., Arimoto T., et al. Serum heart-type fatty acid binding protein predicts cardiac events in elderly patients with chronic heart failure. J Cardiol 46 (2005) 9-15
28. Goto T., Takase H., Toriyama T., et al. Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure. Heart 89 (2003) 1303-1307
29. Knowlton A.A., Apstein C.S., Saouf R., and Brecher P. Leakage of heart fatty acid binding protein with ischemia and reperfusion in the rat. J Mol Cell Cardiol 21 (1989) 577-583
30. Takahashi H., Kawaguchi H., Iizuka K., and Yasuda H. The leakage of fatty acid binding protein from cultured myocardial cells during hypoxia. Cardiovasc Drugs Ther 5 (1991) 1021-1026